Trademark: 90606612
Status Date
Monday, September 5, 2022
Filing Date
Friday, March 26, 2021
Published for Opposition
Tuesday, December 7, 2021
Abandoned Date
Monday, September 5, 2022
42 Custom design, development and optimization of new drug molecules, chemical reagents and biochemical assays; scientific and technological services, namely, custom design and development of new chemical and biological molecules with drug-like properties, in silico computations of molecular interactions, modulation of human leukocyte antigens (HLA) proteins in the field of disease such as autoimmunity; pharmaceutical research and development; scientific research for medical and drug development purposes in the fields of immunotherapy, autoimmune diseases and disorders; development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research services; research in the field of pharmaceuticals for the treatment of immunological diseases and disorders; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Sep 6, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 5, 2022
Abandonment - No Use Statement Filed
Feb 1, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 7, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 7, 2021
Published For Opposition
Nov 17, 2021
Notification Of Notice Of Publication E-Mailed
Nov 3, 2021
Approved For Pub - Principal Register
Nov 3, 2021
Examiner's Amendment Entered
Nov 3, 2021
Notification Of Examiners Amendment E-Mailed
Nov 3, 2021
Examiners Amendment E-Mailed
Nov 3, 2021
Examiners Amendment -Written
Nov 3, 2021
Assigned To Examiner
Jul 2, 2021
New Application Office Supplied Data Entered In Tram
Mar 30, 2021
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
